Apoptosis

Apoptosis is a highly regulated form of programmed cell death. It occurs in multicellular organisms and some single-celled microorganisms, such as yeast. This process is essential for maintaining health and proper development during a life cycle. Unlike necrosis, which is a traumatic form of cell death caused by acute injury, apoptosis is a controlled biological event.

During apoptosis, biochemical events trigger specific changes in the cell's shape and structure. These changes include cell shrinkage, chromatin condensation, and DNA fragmentation. The cell also undergoes blebbing and mRNA decay. Eventually, the cell breaks into small fragments called apoptotic bodies.

These fragments are then engulfed by phagocytes. This tidy removal prevents cellular contents from spilling out and damaging surrounding cells.

There are two primary pathways that initiate apoptosis: the intrinsic pathway and the extrinsic pathway. The intrinsic pathway is also known as the mitochondrial pathway. It is triggered by intracellular signals when a cell senses internal stress. Examples of such stress include nutrient deprivation, viral infection, hypoxia, or radiation.

In this pathway, proteins like Bax and Bak create pores in the mitochondrial membrane. This allows cytochrome c to leak out into the cytosol. Once released, cytochrome c binds with Apaf-1 and ATP to form a complex called an apoptosome. The apoptosome then activates caspase-9, which eventually triggers the executioner caspases to dismantle the cell. Additionally, mitochondria release SMAC proteins, which deactivate inhibitors that would otherwise stop the death process.

The extrinsic pathway is activated by signals from outside the cell. This occurs when external ligands bind to specific death receptors on the cell surface. One major mechanism involves the TNF-induced model. TNF, or tumor necrosis factor, is a cytokine produced mainly by activated macrophages. When TNF binds to the TNFR1 receptor, it initiates a signaling chain involving proteins like TRADD and FADD.

Another important mechanism is the Fas pathway. This involves the Fas receptor, a transmembrane protein that binds to the Fas ligand. This interaction leads to the formation of the death-inducing signaling complex, or DISC. These pathways ensure that cells receive precise instructions on when to undergo programmed death.

Both pathways eventually converge on the activation of caspases. Caspases are proteases, which are specialized enzymes that degrade proteins. The process begins with initiator caspases, which are the first to be activated by the signaling pathways. These initiator caspases then activate executioner caspases. These executioner enzymes act indiscriminately to break down the cell's proteins. Because apoptosis cannot be stopped once it has begun, the entire process must be tightly regulated by various proteins. For example, the Bcl-2 family of proteins can inhibit apoptosis, while others, like Fas receptors, promote it.

The history of apoptosis research spans many decades. German scientist Carl Vogt first described the principle in 1842. In 1885, anatomist Walther Flemming provided a more precise description of programmed cell death. However, the field was truly revitalized in 1965 by John Kerr at the University of Queensland. Using electron microscopy, Kerr distinguished apoptosis from traumatic necrosis. He later collaborated with Alastair Currie and Andrew Wyllie at the University of Aberdeen. In 1972, they published a seminal article in the British Journal of Cancer. They used the term "apoptosis," a name suggested by Greek professor James Cormack.

The term is derived from the Greek word for the "falling off" of leaves or petals.

Understanding the scale of this process reveals its biological importance. An average adult human loses between 50 and 70 billion cells every day to apoptosis. For a child between the ages of 8 and 14, the loss is approximately 20 to 30 billion cells per day. This massive turnover is necessary for growth and maintenance. For instance, apoptosis is responsible for the separation of fingers and toes in a developing human embryo. The cells located between the digits undergo genetically determined death to shape the limbs.

Without this precise removal of cells, the body would not develop its correct form.

Defects in apoptotic processes are linked to many human diseases. If apoptosis is excessive, it can cause atrophy, where tissues waste away. If there is an insufficient amount of cell death, it can lead to uncontrolled cell proliferation, such as cancer. In 1988, researchers discovered that the BCL2 gene, which is linked to follicular lymphoma, encodes a protein that inhibits cell death. This discovery helped link cell death abnormalities to human disease. In 2002, the Nobel Prize in Medicine was awarded to Sydney Brenner, H. Robert Horvitz, and John Sulston. They were recognized for identifying the genes that control apoptosis in the nematode C. elegans.

These same genes function in humans to regulate the balance of cell life and death.